Street-grade product cut with chemicals no one could pronounce. A consumer base with no access to legitimate wellness alternatives. A market stuck, stagnant, and dominated by mediocrity. NeuroBotanics was built to destroy that status quo.
Lafayette spent four years at the intersection of molecular genetics and applied pharmacology, pursuing a singular objective: engineer a stable, psychoactive hemp strain through DNA modification rather than chemical synthesis. The premise was unambiguous — if the plant could be instructed to produce the compound natively, the result would be cleaner, more consistent, and legally defensible in ways that post-harvest additives never could be.
The result of that work is SOMA-9®. A proprietary strain derived from bio-modified seeds, where thermo-active tryptamine is expressed naturally through the plant's own biochemical pathways. The strain is stable across generations. It is batch-consistent. It has passed preliminary toxicological review. It is registered.
NeuroBotanics was incorporated not as a passion project, but as a deliberate market intervention. Lafayette identified the gap — consumers in Los Santos with genuine interest in cognitive enhancement and no access to legitimate, tested product — and built the infrastructure to fill it. Not a garage operation. Not a start-up myth. A precision business backed by institutional capital from day one.
"The Los Santos market was not waiting to be disrupted. It was waiting to be replaced. There is a difference. We are not here to compete with the street. We are here to make the street irrelevant."
— Malcolm Lafayette, CEONeuroBotanics operates from a headquarters located in the Los Santos tech-business district — a zone zoned for high-technology companies and biomedical research. The facilities are not rented. They are owned and purpose-built.
Automated, climate-controlled clean rooms for adaptogenic mushroom cultivation. Lion's Mane, Chaga, and Reishi are grown in-house under ISO-standard sterile conditions. No cross-contamination. No external supply chain dependency.
A dedicated cultivation wing houses the SOMA-9® crop. Automated environmental controls — humidity, light cycle, CO₂ — maintain batch consistency across every harvest. Every crop is tested prior to release.
In-house laboratory for N-ZYME MATRIX formulation, extract concentration, and QA testing. On-site biomarker analysis for client consultations is conducted within this facility.
The consumer-facing experience space within HQ. Engineered atmosphere, acoustic treatment, and controlled lighting. Available to members 24/7/365 and walk-in clients during operating hours.
Headquarters located within the Los Santos innovation and biotech corridor — co-located with high-technology firms and research incubators. Not a warehouse. Not a pop-up.
From seed modification to final product formulation — every stage of the NeuroBotanics supply chain operates within a single owned facility. No third-party processing. Full traceability.
NeuroBotanics is not a garage experiment. From incorporation, the company has been capitalized by institutional venture capital — funds allocated directly to technology infrastructure, laboratory equipment, and facility build-out.
The investment thesis is straightforward: a defensible proprietary compound, a legally authorized product, and a vertically integrated operation with no comparable competitor in the Los Santos market. Investors did not bet on a supplement trend. They bet on a market monopoly.
NeuroBotanics operates by appointment. Everything begins with a conversation.
// Contact via Discord